Ocata Therapeutics Appoints Dr. Brian Levy to its Board of Directors

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (NASDAQ:OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that Brian Levy, O.D., M.Sc., has joined Ocata's Board of Directors. Most recently, Dr. Levy served as Chief Medical Officer of Aerie Pharmaceuticals, Inc. "Brian has been a widely regarded leader in the pharmaceutical industry for more than two decades, including fifteen years at Bausch + Lomb where he was the Chief Medical Officer and he brings sig